Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 6/20 | 0.43 |
| ▸ | CXCL10 | P02778 | 1/20 | 0.39 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.39 |
| ▸ | CCL2 | P13500 | 1/20 | 0.39 |
| ▸ | CCL5 | P13501 | 1/20 | 0.39 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.39 |
| ▸ | M6PR | P20645 | 2/20 | 0.38 |
| ▸ | SERPINC1 | P01008 | 2/20 | 0.37 |
| ▸ | FGF1 | P05230 | 2/20 | 0.36 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.35 |
| ▸ | BDNF | P23560 | 3/20 | 0.35 |
| ▸ | PTN | P21246 | 2/20 | 0.35 |
| ▸ | MDK | P21741 | 2/20 | 0.35 |
| ▸ | G6PD | P11413 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12901064 | 1.00 | F10 (0.43) | F10CXCL10CXCL8CCL2CCL5 | |
| SCHEMBL20363815 | 1.00 | F10 (0.43) | F10CXCL10CXCL8CCL2CCL5 | |
| SCHEMBL14030121 | 1.00 | F10 (0.43) | F10CXCL10CXCL8CCL2CCL5 | |
| SCHEMBL20370858 | 1.00 | F10 (0.43) | F10CXCL10CXCL8CCL2CCL5 | |
| SCHEMBL12755226 | 1.00 | F10 (0.43) | F10CXCL10CXCL8CCL2CCL5 | |
| SCHEMBL20363547 | 1.00 | F10 (0.43) | F10CXCL10CXCL8CCL2CCL5 | |
| SCHEMBL12878540 | 1.00 | F10 (0.43) | F10CXCL10CXCL8CCL2CCL5 | |
| SCHEMBL12458629 | 1.00 | F10 (0.43) | F10CXCL10CXCL8CCL2CCL5 | |
| SCHEMBL22139521 | 1.00 | F10 (0.43) | F10CXCL10CXCL8CCL2CCL5 | |
| SCHEMBL18309852 | 1.00 | F10 (0.43) | F10CXCL10CXCL8CCL2CCL5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12030963-B2 | Matrices comprising a modified polysaccharide | MAPTECH HOLDINGS UG (DE) | 2024-07-09 | — | — | US | disclosed |
| US-20240218164-A1 | POLYMER COMPOSITION AND PREPARATION METHOD THEREFOR | YOUREH CO., LTD. (KR) | 2024-07-04 | — | — | US | disclosed |
| US-20240216575-A1 | BIOPOLYMER SCAFFOLDS AND METHODS FOR PRODUCTION OR USE THEREOF | BIONOVA MEDICAL, INC. (US) | 2024-07-04 | — | — | US | disclosed |
| US-20230292814-A1 | Polysaccharide-Based Tobacco Gel Compositions | VMR PRODUCTS LLC | 2023-09-21 | — | — | US | disclosed |
| US-9995709-B2 | Substrate modification method | ARKRAY, INC. (JP) | 2018-06-12 | — | — | US | disclosed |
| US-20180143210-A1 | DEVICE AND METHODS OF USING DEVICE FOR DETECTION OF HYPERAMMONEMIA | UNIVERSITY OF MARYLAND, COLLEGE PARK (US) | 2018-05-24 | — | — | US | disclosed |
| US-9952199-B2 | Device and methods of using device for detection of hyperammonemia | UNIVERSITY OF MARYLAND, COLLEGE PARK (US) | 2018-04-24 | — | — | US | disclosed |
| US-20180043066-A1 | MACROINITIATORS FOR HYDROPHILIC COATINGS ON LATEX AND APPLICATIONS THEREOF | TRUSTEES OF BOSTON UNIVERSITY (US) | 2018-02-15 | — | — | US | disclosed |
| US-20170198329-A1 | DEVICE AND METHODS OF USING DEVICE FOR DETECTION OF AMINOACIDOPATHIES | UNIVERSITY OF MARYLAND, COLLEGE PARK (US) | 2017-07-13 | — | — | US | disclosed |
| US-20170146459-A1 | HYDROGEL, PREPARATION METHOD THEREOF, AND pH SENSOR COMPRISING THE SAME | INDUSTRY-ACADEMIC COOPERATION FOUNDATION YONSEI UNIVERSITY (KR) | 2017-05-25 | — | — | US | disclosed |
| US-9441051-B2 | Matrices comprising modified polysaccharides and modified polysaccharides | ALBERT LUDWIGS UNIVERSITÄFREIBURG (DE) | 2016-09-13 | — | — | US | disclosed |
| US-9433644-B2 | Formulations and methods for treating oral inflammation, injury, or pain | RUTGILLI PHARMACEUTICALS, LLC (US) | 2016-09-06 | — | — | US | disclosed |
| US-20160231310-A1 | Device And Methods Of Using Device For Detection Of Hyperammonemia | UNIVERSITY OF MARYLAND, COLLEGE PARK | 2016-08-11 | — | — | US | disclosed |
| US-20150362437-A1 | HYDROGEL, PREPARATION METHOD THEREOF, AND pH SENSOR COMPRISING THE SAME | INDUSTRY-ACADEMIC COOPERATION FOUNDATION YONSEI UNIVERSITY (KR) | 2015-12-17 | — | — | US | disclosed |
| US-20150119783-A1 | Method of Preparation of Polysaccharide Fibres, Wound Covers that Contain Them, Method of Manufacturing of Wound Covers, and Apparatus for Preparation of Polysaccharide Fibres | CONTIPRO BIOTECH S.R.O. (CZ) | 2015-04-30 | — | — | US | disclosed |
| US-20150030694-A1 | FORMULATIONS AND METHODS FOR TREATING ORAL INFLAMMATION, INJURY, OR PAIN | INVADO LABORATORIES, LLC | 2015-01-29 | — | — | US | disclosed |
| US-8673992-B2 | Polyurethane gel foams | PAUL HARTMANN AG (DE) | 2014-03-18 | — | — | US | disclosed |
| US-20130105316-A1 | Substrate Modification Method | ARKRAY, INC. (JP) | 2013-05-02 | — | — | US | disclosed |
| US-20110196329-A1 | POLYURETHANE GEL FOAMS | PAUL HARTMANN AG (DE) | 2011-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150030694-A1 | FORMULATIONS AND METHODS FOR TREATING ORAL INFLAMMATION, INJURY, OR PAIN | CD44, TRPV1, IL6 | F10 712/4885CXCL10 150/4885CXCL8 89/4885 |
| US-20180143210-A1 | DEVICE AND METHODS OF USING DEVICE FOR DETECTION OF HYPERAMMONEMIA | ASS1, ALPL, SLCO2B1 | F10 1052/4885CXCL10 1168/4885CXCL8 916/4885 |
| US-12030963-B2 | Matrices comprising a modified polysaccharide | FUT5, FUT6, CSGALNACT1 | F10 162/4885CXCL10 316/4885CXCL8 1955/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.